News
26 July, 2022 26 July, 2022 Opinion of the Transparency Council – changes to the drug programme B.61
read more26 July, 2022 Opinion of the Transparency Council – active substance ipratropii bromidum
read more26 July, 2022 Opinion of the Transparency Council – active substances fenoteroli hydrobromidum + ipratropii bromidum
read more26 July, 2022 Opinion of the Transparency Council – active substance prednisone
read more26 July, 2022 Opinion of the Transparency Council – active substances amiloridum + hydrochlorothiazidum
read more26 July, 2022 Opinion of the Transparency Council – health policy programme on medical rehabilitation (Municipality of Mielno)
read more26 July, 2022 Opinion of the Transparency Council – health policy programme on detection of vision defects (Municipality of Chociwel)
read more26 July, 2022 Opinion of the Transparency Council – health policy programme on detection of vision defects (town of Będzin)
read more26 July, 2022 Position of the Transparency Council – Rezurock (belumosudil)
read more26 July, 2022 Position of the Transparency Council – Yervoy (ipilimumab)
read more26 July, 2022 Position of the Transparency Council – Opdivo (nivolumab)
read more26 July, 2022 Opinion of the Transparency Council – combining drug programmes B.29 and B.46
read more26 July, 2022 Position of the Transparency Council – non gamma 2 capsule amalgam
read more21 July, 2022 The Meeting of the Transparency Council No. 29/2022 of 25.07.2022
read more20 July, 2022 Communication on the meeting of the Tariff Council on 14.07.2022
read more19 July, 2022 The Meeting of the Tariffs Council No. 18/2022 of 28.07.2022
read more18 July, 2022 Opinion of the President – ,,Prevention of overweight and obesity in children in class III of primary schools in the Municipality of Kołobrzeg for the period 2022 – 2024”
read more15 July, 2022 The Meeting of the Tariffs Council No. 17/2022 of 21.06.2022
read more13 July, 2022 Announcement of the President – recommendation on the change of the method or level of healthcare service financing
read more13 July, 2022 Opinion of the Transparency Council – leflunomidum
read more13 July, 2022 Position of the Transparency Council – Livmarli (maralixibat)
read more13 July, 2022 Opinion of the Transparency Council – health policy programme of the Municipality of Kołobrzeg in the scope of prevention of overweight and obesity in children
read more13 July, 2022 The Meeting of the Transparency Council No. 28/2022 of 18.07.2022
read more